<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
RYTM
Rhythm Pharmaceuticals
$
()


  • Rhythm Pharmaceuticals secures $150M in convertible preferred stock financing

    4/1/2024 - 08:19am
  • Rhythm announces first patient dosed in Phase 1 trial of RM-718

    3/25/2024 - 08:15am
  • Stifel ups Rhythm Pharmaceuticals target, calls pullback buying opportunity

    2/22/2024 - 13:17pm
  • Rhythm Pharmaceuticals announces development plan of setmelanotide

    2/22/2024 - 07:28am
  • Rhythm Pharmaceuticals sees 2024 operating expenses $250M-$270M

    2/22/2024 - 07:11am
  • Rhythm Pharmaceuticals announces upcoming milestones

    2/22/2024 - 07:09am
  • Rhythm Pharmaceuticals reports Q4 EPS (70c), consensus (70c)

    2/22/2024 - 07:08am
  • Rhythm Pharmaceuticals announces reimbursement decision in Italy for IMCIVREE

    2/7/2024 - 08:15am
  • Biotech Alert: Searches spiking for these stocks today

    1/26/2024 - 11:25am
  • Rhythm Pharmaceuticals price target raised by $18 at BofA, here's why

    1/12/2024 - 06:38am
  • Rhythm announces global licensing agreement with LG Chem for LB54640

    1/4/2024 - 07:18am
  • Rhythm Pharmaceuticals completes screening for Phase 3 setmelanotide trial

    1/4/2024 - 06:59am
  • Rhythm Pharmaceuticals just upgraded at Morgan Stanley, here's why

    12/19/2023 - 07:10am
  • Rhythm Pharmaceuticals price target raised by $8 at Ladenburg, here's why

    12/7/2023 - 14:29pm
  • Rhythm Pharmaceuticals price target raised to $45 from $32 at Needham

    12/7/2023 - 07:45am
dynamic_feed Breaking News